Forbes

CRISPR, Editas, Intellia: Gene Editing Stocks To Play The Next Revolution In Medicine

CRISPR, Editas, Intellia: Gene Editing Stocks To Play The Next Revolution In Medicine

Gene editing has emerged as a promising biotech theme. The technology is used to insert, edit, or delete a gene from an organism’s genome, helping to replace the defective genes responsible for a medical condition with healthy versions. This technology is being used to develop treatments for a…

Source: Forbes – Markets
Date: January 12, 2021, 01:55